Souvannavong V, Adam A
Biochem Biophys Res Commun. 1984 Nov 30;125(1):431-9. doi: 10.1016/s0006-291x(84)80386-1.
MDP, a synthetic muramyl dipeptide, is capable of increasing the primary in vitro antibody response, to sheep erythrocytes, of purified B cells restored with a monokine and helper T cell factors, including Interleukin 2 and the late-acting T cell replacing factor (TRF). First, the possibility that the adjuvanticity of MDP could be due to the elaboration of Interleukin 1, caused by its effect on macrophages, was excluded. In addition, a kinetic study showed that the effect of MDP was greater when added later, concomitantly with or one day after the helper T cell factors. Therefore, it appears that MDP acts directly on B cells, in a late stage of their differentiation to antibody-producing cells.
MDP是一种合成的胞壁酰二肽,它能够增强纯化的B细胞对绵羊红细胞的体外初次抗体反应,这些B细胞是用一种单核因子和辅助性T细胞因子(包括白细胞介素2和晚期作用的T细胞替代因子(TRF))恢复的。首先,排除了MDP的佐剂活性可能是由于其对巨噬细胞的作用而产生白细胞介素1这一可能性。此外,一项动力学研究表明,当在辅助性T细胞因子之后、与之同时或之后一天添加MDP时,其效果更佳。因此,似乎MDP在B细胞分化为抗体产生细胞的后期直接作用于B细胞。